Our Science – Michalowski Website
Aleksandra M. Michalowski, M.Sc., Ph.D.
Dr. Michalowski develops biostatistical and bioinformatic approaches for the design and analysis of preclinical cancer research experiments. Her primary focus is genomic studies, which include integration and biological interpretation of large-scale transcriptional signatures from cancer models and patients across a variety of cancer types (multiple myeloma, breast cancer, melanoma and non-melanoma skin cancers, prostate cancer, and lung cancer), modeling of genomic networks, analysis workflows for next-generation sequencing data, and preclinical development of predictive signatures for cancer treatments. Her most recent project involves development of new algorithms for screening of anti-cancer synergistic drug combinations based on high-throughput in vitro assays. Dr. Michalowski conducts collaborative research within the Laboratory of Cancer Biology and Genetics, the Biometric Research Branch (DCTD), and the National Center for Advancing Translational Sciences (NCATS) at NIH.
Gene expression signatures of neoplasm responsiveness to therapy.
PCT Application No. PCT/US2012/064693 NIH (DHHS)
Reference No. E-013-2012/0-PCT-02
National stage filing in progress.
This page was last updated on 7/9/2014.